The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.

 
Web www.patentalert.com

< Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors

> Ligand to GPR8

> Fibroblast growth factor-like polypeptides and variants thereof
~ 00516